Clinical Trials Directory

Trials / Unknown

UnknownNCT06182098

Intravenous Fluids in Pediatric Migraine

Value of Intravenous Fluids in the Emergent Treatment of Pediatric Migraine

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
134 (estimated)
Sponsor
Dayton Children's Hospital · Academic / Other
Sex
All
Age
5 Years – 21 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to compare intravenous (IV) fluids in pediatric patients with migraine. The main questions it aims to answer are: * Does a large amount of fluids (bolus) improve pain * Does a large amount of fluids (bolus) reduce admissions to the hospital for migraine Participants will be asked to report their pain and have vital signs checked every 30 minutes for two hours. Researchers will compare a large amount of fluids (bolus) to a small amount (half maintenance) to see if there is a difference in pain improvement.

Detailed description

Patients will be randomized to one of two treatment groups. The intervention group will receive a 20 mL/kg bolus of normal saline (with a maximum of 1L), given over one hour. The control group will receive normal saline at half maintenance (with a maximum of 50mL/hr) over one hour. Both groups will receive: * ketoralac (Toradol), 0.5mg/kg, with a maximum of 30mg * diphenhydramine(Benadryl), 0.5mg/kg, with a maximum of 25mg * prochlorperazine(Compazine), 0.15mg/kg, with a maximum of 10mg Pain score, heart rate, and blood pressure will be monitored every 30 minutes from the start of the medications/fluids being started, for a period of two hours. Pain will be recorded using a 100mm visual analog scale.

Conditions

Interventions

TypeNameDescription
OTHER1/2 maintenance fluidsPatients will receive 1/2 maintenance normal saline (with a maximum of 50 mL/hr), over one hour.
DRUGKetorolac0.5mg/kg, with a maximum of 30mg
DRUGDiphenhydramine0.5mg/kg, with a maximum of 25mg
DRUGProchlorperazine0.15mg/kg, with a maximum of 10mg
OTHERbolus20mL/kg normal saline bolus, with a maximum of 1L, given over one hour

Timeline

Start date
2023-06-27
Primary completion
2025-06-01
Completion
2025-06-01
First posted
2023-12-26
Last updated
2023-12-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06182098. Inclusion in this directory is not an endorsement.